Unwinding the Psychopharmacology of Anxiety Treatment in Women
- Speaker:
- David Dadiomov, PharmD, BCPP
- Duration:
- 2 Hours 05 Minutes
- Format:
- Audio and Video
- Copyright:
-
Aug 30, 2024
- Product Code:
- POS078870
- Media Type:
- Digital Seminar
Description
Women experience anxiety disorders at a higher rate than men. In addition to this higher rate, women have unique concerns and considerations when it comes to treatment with medications. Join Dr. David Dadiomov, a board-certified psychiatric pharmacist, as he provides a comprehensive look at the complexities involved in treating anxiety disorders in women. Advance your understanding of the biological underpinnings of fear and stress responses, the neurotransmitters involved, and the role of hormones in producing these symptoms.
Gain expert insights into the unique pharmacologic targets and primary medication classes tailored for women, including SSRIs, SNRIs, gabapentinoids, and benzodiazepines. Learn practical strategies for initiating, monitoring, and adjusting anxiety medications to ensure maximum tolerability and efficacy. Special focus is given to anxiety treatment during pivotal life stages, from pre-pregnancy and pregnancy to post-partum, providing you with the knowledge to make informed decisions to understand how to optimize medication regimens. Equip yourself with the latest, evidence-based practices to deliver personalized and effective anxiety care for women.
Credit
Speaker
David Dadiomov, PharmD, BCPP Related seminars and products
David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.
He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.
Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.
Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California Psychiatry and behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He previously received a speaking honorarium from Eli Lilly. Dr. Dadiomov receives grants from the 2024 SC CTSI Standard Pilot Grand Program, the USC Good Neighbors Grant Program, the Southern California Clinical and Translational Sciences Institute, and the Foundation for Opioid Response Efforts. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the American Association of Psychiatric Pharmacists, the American College of Clinical Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please contact cepepesi.com
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Explain the neurological basis and neurotransmitters involved in anxiety disorders in women
- Identify the pharmacologic targets used in the treatment of anxiety disorders in women
- Apply psychopharmacology concepts to current medication treatment and education of anxiety disorders in women
- Evaluate anxiety disorders, their treatment, risks, and benefits to promote optimal patient outcomes.
Outline
The Psychopharmacology of Anxiety
- How anxiety and fear manifest in the brain
- The neurotransmitters involved in anxiety disorders
- Pharmacologic targets used in the treatment of anxiety disorders in women
Anxiety Treatment Medications
- Main classes of medications used in the treatment of anxiety disorders, with an emphasis on unique attributes to women
- How to initiate medications for maximum tolerability
- Strategies to monitor and titrate medications for efficacy:
- SSRIs
- SNRIs
- Gabepentinoids
- Benzodiazepines
Pre-natal Anxiety
- Evidence based anxiety treatment in women prior to pregnancy
Anxiety in Pregnancy
- Risks and benefits of anxiety treatment on patients continuing medications into pregnancy
- Differences in the pharmacokinetics of pregnancy
Post-partum Anxiety
- Lactation considerations with medications
- Treatment of anxiety post-partum and duration of treatment
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...